Niki BioSolutions, Inc. (NIKI) stock
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
$1.60+0.10 (+6.67%)
Close on Nov 18, 2026Market cap $13.03MP/E –Yield –
Niki BioSolutions price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Niki BioSolutions's price to sales ratio was 121.6× on Jan 31, 2025, against 46.8× a year earlier. Over the last 3 years it ranged from 45.4× to 459.2×, with a median of 125.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 121.6× | −171.9 |
| 2024 | Dec 31, 2024 | 293.5× | +226.0 |
| 2023 | Dec 29, 2023 | 67.4× | −57.6 |
| 2022 | Dec 30, 2022 | 125.0× | – |
See a number that looks wrong?